Ainhoa Mendizabal has been a member of the Board of Management of Biotest AG since February 2023. As Chief Financial Officer, Ms Mendizabal is responsible within the Biotest Group for the areas of finance including the treasury and tax department, controlling, investor relations and insurance. Previously, Ms Mendizabal held various executive and managerial positions in the Grifols Group in Germany and in Europe. Ms Mendizabal also worked for several years in an international consulting firm in the area of CFO Services and Enterprise Applications. From there, she moved to Talecris Biotherapeutics GmbH before Talecris was acquired by Grifols S.A.. Ainhoa Mendizabal holds a dual Master of Business Administration in Germany and Spain. Ms Mendizabal was born in 1972.
Previous companies
February, 2023 - present